BP885

Etoposid

British Pharmacopoeia (BP) Reference Standard

• Synonym(e): 4′-Demethylepipodophyllotoxin 9-(4,6-O-ethyliden-β-D-glucopyranosid), VP-16-213
• Empirische Formel (Hill-System): C₂₉H₃₂O₁₃
• CAS-Nummer: 33419-42-0
• Molekulargewicht: 588.56
• EG-Nummer: 251-509-1
• MDL-Nummer: MFCD00869325
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: etoposide
• Form: solid
• Haltbarkeit: limited shelf life, expiry date on the label
• Hersteller/Markenname: BP
• Anwendung(en): pharmaceutical; pharmaceutical small molecule
• Format: neat
• Lagertemp.: 2-8°C
• SMILES String: COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26
• InChI: 1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1
• InChIKey: VJJPUSNTGOMMGY-MRVIYFEKSA-N
• Angaben zum Gen: human ... TOP2A(7153) , TOP2B(7155)

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Etoposide BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Etoposide Oral Solution

Etoposide Capsules

Etoposide Infusion

Biochem./physiol. Wirkung

Etopsid ist ein Antitumormittel, das Komplexe mit Topoisomerase II und DNA bildet, um die Doppelstrang- und Einzelstrangspaltung von DNA zu verstärken und die erneute Ligation reversibel zu hemmen. Blockiert den Zellzyklus in der S-Phase und G2-Phase des Zellzyklus; leitet die Apoptose in normalen und Tumorzelllinien ein; hemmt die Synthese des Onkoproteins MDM2 und leitet die Apoptose in Tumorzelllinien, die MDM2 überexprimieren ein.

Verpackung

Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS08,GHS07
• Signalwort: Danger
• H-Sätze: H302,H350,H361d
• P-Sätze: P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 4 Oral - Carc. 1B - Repr. 2
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3